Free Trial

SBC Medical Group (NASDAQ:SBC) Sees Unusually-High Trading Volume on Strong Earnings

SBC Medical Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • SBC Medical Group beat quarterly expectations, reporting EPS of $0.15 versus $0.12 consensus and revenue of $58.58 million versus estimates of $48.90 million.
  • Trading volume climbed 52% above its daily average after the earnings announcement, with about 198,457 shares traded during midday.
  • BTIG raised its price target to $10 and reiterated a Buy rating; MarketBeat reports an average “Moderate Buy” rating and a $10 average target.
  • Five stocks to consider instead of SBC Medical Group.

Shares of SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report) saw strong trading volume on Monday following a better than expected earnings announcement. Approximately 198,457 shares traded hands during mid-day trading, an increase of 52% from the average daily volume of 130,815 shares. The stock last traded at $6.5910 and had previously closed at $7.35.

The company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.12 by $0.03. SBC Medical Group had a return on equity of 19.14% and a net margin of 27.26%. The company had revenue of $58.58 million for the quarter, compared to analyst estimates of $48.90 million.

Analyst Ratings Changes

Several brokerages have recently weighed in on SBC. BTIG Research upped their price objective on shares of SBC Medical Group from $8.00 to $10.00 and gave the company a "buy" rating in a report on Friday. Wall Street Zen lowered SBC Medical Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday. Finally, Weiss Ratings raised SBC Medical Group from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, October 9th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, SBC Medical Group currently has an average rating of "Moderate Buy" and an average target price of $10.00.

View Our Latest Stock Analysis on SBC

Institutional Trading of SBC Medical Group

Hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in shares of SBC Medical Group during the 2nd quarter valued at about $2,846,000. Russell Investments Group Ltd. grew its stake in shares of SBC Medical Group by 2,810.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 125,991 shares of the company's stock worth $622,000 after buying an additional 121,662 shares during the last quarter. Marshall Wace LLP bought a new stake in SBC Medical Group during the 3rd quarter valued at about $520,000. Citadel Advisors LLC bought a new stake in SBC Medical Group in the 2nd quarter worth about $446,000. Finally, State Street Corp lifted its holdings in shares of SBC Medical Group by 58.9% during the 3rd quarter. State Street Corp now owns 78,232 shares of the company's stock valued at $386,000 after buying an additional 28,993 shares during the period. Institutional investors own 60.82% of the company's stock.

SBC Medical Group Stock Performance

The company has a debt-to-equity ratio of 0.09, a quick ratio of 3.27 and a current ratio of 3.31. The stock has a market cap of $658.22 million, a P/E ratio of 12.84, a P/E/G ratio of 3.30 and a beta of 0.52. The business's 50-day moving average price is $5.13 and its 200-day moving average price is $3.98.

SBC Medical Group Company Profile

(Get Free Report)

SBC Medical Group Holdings provides management and support services to medical institutions, with a focus on clinics offering aesthetic medicine. Its services include support for clinic operations, marketing, staff training, procurement and customer service, allowing affiliated medical providers to focus on patient care. The group is associated with the Shonan Beauty Clinic brand and a broader network of clinics offering services such as cosmetic surgery and dermatology. Its business is centered primarily in Japan, where it supports the operations and growth of affiliated medical institutions.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in SBC Medical Group Right Now?

Before you consider SBC Medical Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.

While SBC Medical Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines